You Myung-Won, Kim So Yeon, Kim Kyoung Won, Lee So Jung, Shin Yong Moon, Kim Jin Hee, Lee Moon-Gyu
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ; Asan Liver Cancer Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ; Department of Radiology, Eulji Hospital, Eulji University School of Medicine, Seoul, Korea.
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ; Asan Liver Cancer Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Clin Mol Hepatol. 2015 Mar;21(1):95-103. doi: 10.3350/cmh.2015.21.1.95.
The role of imaging is crucial for the surveillance, diagnosis, staging and treatment monitoring of hepatocellular carcinoma (HCC). Over the past few years, considerable technical advances were made in imaging of HCCs. New imaging technology, however, has introduced new challenges in our clinical practice. In this article, the current status of clinical imaging techniques for HCC is addressed. The diagnostic performance of imaging techniques in the context of recent clinical guidelines is also presented.
成像在肝细胞癌（HCC）的监测、诊断、分期及治疗监测中发挥着至关重要的作用。在过去几年中，HCC成像技术取得了显著的技术进步。然而，新的成像技术也给我们的临床实践带来了新的挑战。本文阐述了HCC临床成像技术的现状，还介绍了在近期临床指南背景下成像技术的诊断性能。
